Tonix Pharmaceuticals stock halted ahead of FDA approval news
BETHESDA, Md. - Global Medical REIT Inc. (NYSE:GMRE), a healthcare REIT with a market capitalization of $469 million and an attractive dividend yield of 8.9%, announced Tuesday that its Board of Directors has approved a $50 million common stock repurchase program and a one-for-five reverse stock split. According to InvestingPro analysis, the company appears undervalued based on its Fair Value metrics, with strong financial health indicators including a healthy current ratio of 1.32.
The stock repurchase program will allow the company to buy back up to $50 million of its outstanding common shares through various methods including open market purchases, block trades, privately negotiated transactions, or through Rule 10b5-1 trading plans. The company noted that the timing, price, and size of purchases will depend on market conditions, and the program may be suspended or discontinued at any time. InvestingPro subscribers can access additional insights through comprehensive Pro Research Reports, which provide detailed analysis of GMRE’s financials, including its impressive 99.9% gross profit margin and growth prospects.
The reverse stock split, which was approved on August 12, is scheduled to take effect on September 19, 2025, at 5:00 p.m. Eastern Time. Following the split, every five shares of GMRE common stock will be converted into one share, with corresponding adjustments to the company’s authorized shares, equity awards, and operating partnership units.
Trading on a split-adjusted basis is expected to begin on September 22, 2025. The company will continue trading under the NYSE symbol "GMRE" but will receive a new CUSIP number.
Stockholders will not receive fractional shares; instead, they will receive cash based on the closing price of GMRE stock on the effective date. The reverse split will not affect stockholders’ ownership percentages except for minor adjustments from cash payments for fractional shares.
Global Medical REIT is a net-lease medical real estate investment trust that acquires healthcare facilities and leases them to physician groups and healthcare systems, according to the company’s press release statement.
In other recent news, Global Medical REIT Inc. reported its Q2 2025 earnings, showcasing a mixed financial performance. The company achieved a revenue of $37.9 million, which exceeded analyst forecasts of $35.39 million, resulting in a 7.09% positive surprise. However, the earnings per share (EPS) came in at -$0.01, falling short of the expected $0.01. These recent developments highlight the company’s ability to surpass revenue expectations while facing challenges in meeting EPS forecasts. There were no mergers or acquisitions announced in the latest updates. Additionally, no analyst upgrades or downgrades were reported for Global Medical REIT Inc. in the recent period. The company continues to navigate its financial landscape amidst these mixed results.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.